CBX2 and neoplasm: In tumor cells, Cbx2 is up-regulated and has been identified as a potential drug target (Chen et al., 2017; Clermont et al., 2016), whereas our results demonstrate that Cbx2 is down-regulated in macrophages infected with virus.